CD274 and neoplasm: As observed in the single-tumor model, mLOAd703 treatment alone and in combination with checkpoint inhibitors could delay tumor growth in the injected lesion, but in contrast to the previous experiments, monotherapy with anti-PD-L1 induced an initial response in both lesions.